PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver

This publication has 20 references indexed in Scilit:

• 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
  Proceedings of the National Academy of Sciences, 1997
• Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
  Journal of Clinical Investigation, 1997
• 11β-Hydroxysteroid Dehydrogenase
  Published by Elsevier ,1997
• Targeted Disruption of the Peroxisome Proliferator—Activated Receptor α Gene, PPARα
  Annals of the New York Academy of Sciences, 1996
• Expression monitoring by hybridization to high-density oligonucleotide arrays
  Nature Biotechnology, 1996
• 11β-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism
  Biochemical Journal, 1996
• Effect of growth hormone, insulin and dexamethasone on 11 β -hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes
  Life Sciences, 1996
• Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
  Proceedings of the National Academy of Sciences, 1996
• 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.
  Endocrinology, 1995
• Reversible alteration of hepatic messenger RNA species for peroxisomal and non-peroxisomal proteins induced by the hypolipidaemic drug Wy-14,643
  Biochemical Journal, 1983